Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Waldemar Priebe

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Stem Cells (Dayton, Ohio)|May 14, 2015
Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 PathwayAnwar Hossain, Joy Gumin, Feng Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cellsLing-Yuan Kong, Mohamed K Abou-Ghazal, Jun Wei, et al.
Journal of Translational Medicine|February 11, 2016
Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cellsTakashi Shingu, Lindsay Holmes, Verlene Henry, et al.
Journal of Proteome Research|November 11, 2009
Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cellsCarol L Nilsson, Roslyn Dillon, Arugadoss Devakumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2020
Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic EfficacyMartina Ott, Cynthia Kassab, Anantha Marisetty, et al.
CNS Oncology|May 16, 2022
A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant gliomaJohn de Groot, Martina Ott, Jun Wei, et al.
Journal of the National Cancer Institute|September 1, 2016
IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing SarcomaSalah-Eddine Lamhamedi-Cherradi, Brian A Menegaz, Vandhana Ramamoorthy, et al.
Cancer Cell|September 13, 2011
An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymomaJennifer M Atkinson, Anang A Shelat, Angel Montero Carcaboso, et al.
International Journal of Cancer|June 21, 2018
Profiles of brain metastases: Prioritization of therapeutic targetsSherise D Ferguson, Siyuan Zheng, Joanne Xiu, et al.
Cell Genomics|April 18, 2025
Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targetsIga Kołodziejczak-Guglas, Renan L S Simões, Emerson de Souza Santos, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Stem Cells (Dayton, Ohio)|May 14, 2015
Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 PathwayAnwar Hossain, Joy Gumin, Feng Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cellsLing-Yuan Kong, Mohamed K Abou-Ghazal, Jun Wei, et al.
Journal of Translational Medicine|February 11, 2016
Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cellsTakashi Shingu, Lindsay Holmes, Verlene Henry, et al.
Journal of Proteome Research|November 11, 2009
Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cellsCarol L Nilsson, Roslyn Dillon, Arugadoss Devakumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2020
Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic EfficacyMartina Ott, Cynthia Kassab, Anantha Marisetty, et al.
CNS Oncology|May 16, 2022
A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant gliomaJohn de Groot, Martina Ott, Jun Wei, et al.
Journal of the National Cancer Institute|September 1, 2016
IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing SarcomaSalah-Eddine Lamhamedi-Cherradi, Brian A Menegaz, Vandhana Ramamoorthy, et al.
Cancer Cell|September 13, 2011
An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymomaJennifer M Atkinson, Anang A Shelat, Angel Montero Carcaboso, et al.
International Journal of Cancer|June 21, 2018
Profiles of brain metastases: Prioritization of therapeutic targetsSherise D Ferguson, Siyuan Zheng, Joanne Xiu, et al.
Cell Genomics|April 18, 2025
Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targetsIga Kołodziejczak-Guglas, Renan L S Simões, Emerson de Souza Santos, et al.
Pageof 13